Table 6.
Association of the Level of MmiR‐126 With Baseline Characteristics
| Exp(B) (95% CI) | P Value | |
|---|---|---|
| Age | 1.021 (0.983 to 1.060) | 0.579 |
| Male sex | 0.586 (0.251 to 1.369) | 0.248 |
| Body mass index | 0.932 (0.858 to 1.012) | 0.255 |
| Hypertension | 0.967 (0.354 to 2.638) | 0.611 |
| Hyperlipoproteinemia | 0.958 (0.376 to 2.445) | 0.632 |
| Diabetes | 0.895 (0.397 to 2.020) | 0.688 |
| Family history of CAD | 2.377 (0.874 to 6.469) | 0.452 |
| Smoking | 0.903 (0.341 to 2.391) | 0.463 |
| History of myocardial infarction | 1.672 (0.750 to 3.729) | 0.749 |
| Chronic kidney disease | 0.867 (0.331 to 2.272) | 0.881 |
| Number of diseased vessels | 0.799 (0.573 to 1.115) | 0.197 |
| Left ventricular ejection fraction | 1.009 (0.987 to 1.031) | 0.254 |
| ACE inhibitors | 1.074 (0.498 to 2.318) | 0.232 |
| Beta blockers | 0.852 (0.381 to 1.907) | 0.972 |
| Statins | 0.810 (0.355 to 1.846) | 0.123 |
| Annexin/CD31+ MV | 0.629 (0.305 to 1.296) | 0.881 |
The coefficient of the continuous variables was relative to 1‐U differences. Binary logistic regression according to the median of MmiR‐126 level. ACE indicates angiotensin‐converting enzyme; CAD, coronary artery disease; Exp(B), exponentiation of the B coefficient; MmiR, microRNA in circulating microvesicles; MV, microvesicles.